Abstract
Recent intensification of the controversy surrounding drug-eluting stents (DESs) has polarized opinion on how best to manage patients referred for percutaneous coronary intervention. In this Viewpoint, Farkouh et al. advocate a strategy of profiling patients to determine their suitability for DES implantation, based on their individual risk of developing late-stent thrombosis or bleeding associated with prolonged antiplatelet therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
